Document is current
Any future updates will be listed below
-
Authors
Baldassar, Laura
Cendron, Laura
Facchin, Sonia
Redavid, Carlo
Barberio, Brigida
Jorkesh, Alireza
Dettin, Monica
Pasquato, Antonella
Savarino, Edoardo Vincenzo
- License Information
-
More Information
Article History
Received: 30 July 2025
Accepted: 9 December 2025
First Online: 17 December 2025
Competing interests
: Conflict of interests: Edoardo Vincenzo Savarino has served as speaker for Abbvie, Agave, AGPharma, Alfasigma, Aurora Pharma, CaDiGroup, Celltrion, Dr Falk, EG Stada Group, Fenix Pharma, Fresenius Kabi, Galapagos, Janssen, JB Pharmaceuticals, Innovamedica/Adacyte, Malesci, MayolyBiohealth, Omega Pharma, Pfizer, Reckitt Benckiser, Sandoz, SILA, Sofar, Takeda, Tillots, Unifarco; has served as a consultant for Abbvie, Agave, Alfasigma, Biogen, Bristol-Myers Squibb, Celltrion, DiademaFarmaceutici, Dr. Falk, Fenix Pharma, Fresenius Kabi, Janssen, JB Pharmaceuticals, Merck & Co, Nestlè, Reckitt Benckiser, Regeneron, Sanofi, SILA, Sofar, Synformulas GmbH, Takeda, Unifarco; he received research support from Pfizer, Reckitt Benckiser, SILA, Sofar, Unifarco, Zeta Farmaceutici.
